Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists

1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists

US Patent 7199142 · Granted Apr 3, 2007

Estimated economic value: $51,895,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (2025
RNAi agents for inhibiting expression of HIF-2 alpha (EPAS1), compositions there2025
Alpha-v beta-6 integrin ligands and uses thereof2024
Targeting ligands for therapeutic compounds2024
Trialkyne linking agents and methods of use2024
Prekallikrein-modulating compositions and methods of use thereof2024
Alpha-1 antitrypsin (AAT) RNAi agents, compositions including AAT RNAi agents, a2024
Anti-PD-L1 antibodies2023
Integrin ligands and uses thereof2023
RNAi agents for hepatitis B virus infection2023
RNAi agents for Hepatitis B virus infection2022
RNAi agents and compositions for inhibiting expression of Asialoglycoprotein rec2022